GEVELOT S.A.: Weekly report of share buyback November 29, 2022 Read more about GEVELOT S.A.: Weekly report of share buyback November 29, 2022
HERIGE finalizes its acquisition of PORALU Group and becomes one of the leading French manufacturers of industrial joinery Read more about HERIGE finalizes its acquisition of PORALU Group and becomes one of the leading French manufacturers of industrial joinery
MaaT Pharma To Webcast Investor Meeting in Conjunction with ASH 2022 Conference Read more about MaaT Pharma To Webcast Investor Meeting in Conjunction with ASH 2022 Conference
Lysogene Provides Updates and Topline Results from Phase 2/3 AAVance Gene Therapy Clinical Study Read more about Lysogene Provides Updates and Topline Results from Phase 2/3 AAVance Gene Therapy Clinical Study
Pherecydes Pharma Announces the Positive Recommendation of the DSMB For the Continuation of Its Phase II Clinical Study PhagoDAIR in Osteoarticular Infections Caused by Staphylococcus aureus Read more about Pherecydes Pharma Announces the Positive Recommendation of the DSMB For the Continuation of Its Phase II Clinical Study PhagoDAIR in Osteoarticular Infections Caused by Staphylococcus aureus
SII : Résultats du premier semestre de l’exercice 2022/2023 Read more about SII : Résultats du premier semestre de l’exercice 2022/2023
Valneva to Host Investor Day in New York City Read more about Valneva to Host Investor Day in New York City
Solutions 30 refinances and extends its €100-million syndicated loan Read more about Solutions 30 refinances and extends its €100-million syndicated loan
Floatel International Ltd: Third Quarter Interim Report and Presentation Read more about Floatel International Ltd: Third Quarter Interim Report and Presentation
Changes to SES-imagotag's Board of Directors and nomination of Peter Brabeck-Letmathe Read more about Changes to SES-imagotag's Board of Directors and nomination of Peter Brabeck-Letmathe